血清CEA、CA199和CA242对胰腺癌转移诊断的相关性研究 |
投稿时间:2010-12-07 修订日期:2011-06-22 点此下载全文 |
引用本文:马伟刚.血清CEA、CA199和CA242对胰腺癌转移诊断的相关性研究[J].医学研究杂志,2011,40(9):154-156 |
DOI:
|
摘要点击次数: 1163 |
全文下载次数: 1017 |
|
|
中文摘要:目的探讨癌胚抗原(CEA)、糖抗原199(CA199)和糖抗原242(CA242)检测诊断胰腺癌转移的意义。方法应用美国雅培i2000全自动免疫发光仪检测72例胰腺癌转移患者与13例胰腺癌未转移患者血清中CEA、CA199及CA242浓度。结果随着胰腺癌患者临床分期的增加胰腺癌患者血清中CEA、CA199、CA242浓度逐渐增加,临床分期Ⅱ期、Ⅲ期、Ⅳ期患者与Ⅰ期患者及正常对照组血清中CEA、CA199与CA242浓度及阳性率比较P<0.05差异有统计学意义,转移组患者血清中CEA、CA199及CA242浓度与阳性率远高于未转移组P<0.05,差异有统计学意义。应用ROC曲线比较胰腺癌转移组与未转移组血清CEA、CA199及CA242对胰腺转移癌的联合诊断敏感性达到74.5%特异性达到71.2%,优于CEA、CA199及CA242单项检测。结论在胰腺癌转移组患者血清CEA、CA199及CA242浓度与阳性率大于未转移组患者;可以检测胰腺癌患者血清CEA、CA199及CA242浓度来早期判断胰腺癌患者有无转移。 |
中文关键词:胰腺癌转移 肿瘤标志物 CEA CA199 CA242 |
|
The Value of Serum CEA,CA199 and CA242 in the Patients with Metastasis Pancreatic Cancer |
|
|
Abstract:ObjectiveTo explore the the value of serum CEA,CA199 and CA242 in the patients with metastasis pancreatic cancer.MethodsSerum CEA,CA199 and CA242 levels were determined with ABBOTT i2000 automatic immune light-emitting device in 72 patients of metastasis pancreatic cancer and in 13 patients of non-metastasis pancreatic cancer.ResultsHigh levels of serum markers were assocociated with advanced stage of the pancreatic cancer.The serum CEA,CA199 and CA242 levels in 72 patients of metastasis pancreatic cancer were higher than those in patients of non-metastasis pancreatic cancer(P<0.05).ConclusionThe serum CEA,CA199 and CA242 levels and positive rate in patients of metastasis pancreatic cancer are higher than those in patients of non-metastasis pancreatic cancer.So patients with pancreatic cancer can be detected for serum CEA,CA199 and CA242 concentrations to early judge whether there was transferred. |
keywords:Metastasized pancreatic cancer Tumor marker CEA CA199 CA242 |
查看全文 查看/发表评论 下载PDF阅读器 |